We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$553M
AUM Growth
+$21.4M
Cap. Flow
-$13.5M
Cap. Flow %
-2.43%
Top 10 Hldgs %
23.35%
Holding
124
New
1
Increased
20
Reduced
85
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$330K
2
CVGW
Calavo Growers
CVGW
+$265K
3
LH icon
Labcorp
LH
+$226K
4
BUD icon
AB InBev
BUD
+$181K
5
SLB icon
SLB Ltd
SLB
+$180K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.58M
2
GE icon
GE Aerospace
GE
+$1.54M
3
BA icon
Boeing
BA
+$1.17M
4
META icon
Meta Platforms (Facebook)
META
+$865K
5
AAPL icon
Apple
AAPL
+$783K

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 15.63%
3 Industrials 12.54%
4 Communication Services 12.1%
5 Consumer Staples 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EA icon
51
Electronic Arts
EA
$53B
$4.05M 0.73%
38,935
-634
-2% -$70.5K
VOD icon
52
Vodafone
VOD
$36.3B
$3.92M 0.71%
123,009
-3,953
-3% -$118K
HUB.B
53
DELISTED
HUBBELL INC CL-B
HUB.B
$3.75M 0.68%
27,748
-425
-2% -$57.5K
ADP icon
54
Automatic Data Processing
ADP
$106B
$3.73M 0.68%
31,876
-341
-1% -$39K
LLY icon
55
Eli Lilly
LLY
$1.02T
$3.71M 0.67%
43,927
-615
-1% -$52.3K
LH icon
56
Labcorp
LH
$25B
$3.68M 0.66%
27,225
+1,707
+7% +$226K
NWL icon
57
Newell Brands
NWL
$2.38B
$3.58M 0.65%
116,888
+3,633
+3% +$125K
MDT icon
58
Medtronic
MDT
$109B
$3.56M 0.64%
44,552
-147
-0.3% -$11.8K
MDLZ icon
59
Mondelez International
MDLZ
$79.5B
$3.4M 0.61%
79,477
-675
-0.8% -$28.3K
GE icon
60
GE Aerospace
GE
$374B
$3.4M 0.61%
40,632
-16,142
-28% -$1.54M
BRK.B icon
61
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.25M 0.59%
16,395
-175
-1% -$33.2K
CELG
62
DELISTED
Celgene Corp
CELG
$3.04M 0.55%
29,509
+2,925
+11% +$330K
SE
63
DELISTED
Spectra Energy Corp Wi
SE
$2.94M 0.53%
16,875
-410
-2% -$71.5K
GSK icon
64
GSK
GSK
$104B
$2.91M 0.53%
65,645
-3,666
-5% -$169K
YUM icon
65
Yum! Brands
YUM
$41.8B
$2.9M 0.52%
35,577
-764
-2% -$60.4K
MRK icon
66
Merck
MRK
$322B
$2.85M 0.52%
53,162
-550
-1% -$30.5K
BAX icon
67
Baxter International
BAX
$13.5B
$2.83M 0.51%
43,861
-959
-2% -$61.6K
EMR icon
68
Emerson Electric
EMR
$83.9B
$2.79M 0.5%
40,091
-507
-1% -$32.9K
RDS.A
69
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.75M 0.5%
41,410
-1,335
-3% -$84.1K
PXD
70
DELISTED
Pioneer Natural Resource Co.
PXD
$2.56M 0.46%
14,955
+1,068
+8% +$165K
KO icon
71
Coca-Cola
KO
$377B
$2.49M 0.45%
54,309
-4,560
-8% -$210K
INTU icon
72
Intuit
INTU
$86.5B
$2.31M 0.42%
14,643
-685
-4% -$104K
GILD icon
73
Gilead Sciences
GILD
$162B
$2M 0.36%
27,872
-200
-0.7% -$15.2K
PNR icon
74
Pentair
PNR
$10.4B
$1.9M 0.34%
40,091
-380
-0.9% -$17.8K
GWR
75
DELISTED
Genesee & Wyoming Inc.
GWR
$1.87M 0.34%
24,047
+1,040
+5% +$77.7K
1 2
3
4 5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs & Co held 124 positions worth $553M, up 4% from $532M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 2.4%. Jacobs & Co opened 1 new position and exited 2, leaving the 124-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2017 buy was Calavo Growers: 3,598 shares worth $303K.
  • Jacobs & Co added most to Celgene Corp in Q4 2017, an estimated $330K increase.
  • Jacobs & Co's biggest Q4 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.58M.
  • Jacobs & Co fully exited PG&E in Q4 2017, selling an estimated $347K.
  • Jacobs & Co's ten largest holdings make up 23% of its $553M portfolio in Q4 2017.
  • Jacobs & Co opened 1 new position and closed 2 in Q4 2017.
  • Jacobs & Co's portfolio value rose 4% quarter-over-quarter to $553M.

Based on Jacobs & Co's 13F filing for Q4 2017, filed 9 Feb 2018.